Why is Remedium Life falling/rising?

As of 03-Sep, Remedium Lifecare Ltd's stock price is currently at 1.28, reflecting a decline of 0.04 or 3.03%. The stock has underperformed its sector by 3.93% today and has experienced a consecutive fall over the last two days, resulting in a total decline of 7.91% during this period. Over the past week, the stock has remained flat, but it has seen a significant drop of 64.19% year-to-date and an alarming 81.12% decline over the past year. The company has reported negative financial results consistently, with a high Debt to EBITDA ratio of -1.00 times and a drastic fall in net sales by 76.36%. These factors contribute to a negative outlook, as the company has shown poor long-term growth with an annual operating profit decline of 303.30% over the last five years.
In the broader market context, while the Sensex has shown a slight decline of 0.27% over the past week and a modest gain of 3.11% year-to-date, Remedium Lifecare Ltd's performance has been significantly worse, indicating a stark underperformance compared to the market. The stock's risk profile is heightened due to its negative EBITDA and the fact that it has reported losses for the last four consecutive quarters. Despite a rise in investor participation, as indicated by a 27.42% increase in delivery volume, the overall sentiment remains negative, leading to a continued decline in stock price.